Unidad de Gestión Clínica de Endocrinología y Nutrición, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Clínico Virgen de la Victoria, 29010, Málaga, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 29010, Málaga, Spain.
J Clin Endocrinol Metab. 2022 Jul 14;107(8):2203-2215. doi: 10.1210/clinem/dgac332.
CONTEXT: The prevalence of obesity and hypertriglyceridemia is an alarming worldwide health issue. Mitochondria play a central role in these disorders as they control cell metabolism. OBJECTIVE: The aim of the present study was to characterize mitochondrial homeostasis in subcutaneous and visceral adipose tissue (SAT and VAT) in grade III obese patients with and without hypertriglyceridemia. Moreover, this study presents the evaluation of mitochondrial fitness as a marker for hypertriglyceridemia improvement. PATIENTS: Eight control and 12 hypertriglyceridemic (HTG) grade III obese subjects undergoing bariatric surgery were included. MAIN OUTCOME MEASURES: Anthropometric and biochemical data were obtained before and 3 months after surgery. Mitochondrial homeostasis was evaluated by mitochondrial DNA (mtDNA), gene expression and protein abundance in SAT and VAT. RESULTS: Mitophagy-related gene expression was increased in HTG SAT and VAT, while mitochondrial marker gene expression and mtDNA were decreased, indicating an altered mitochondrial homeostasis in HTG. Mitophagy protein abundance was increased in VAT of those subjects that did not improve their levels of triglycerides after bariatric surgery, whereas mitochondrial protein was decreased in the same tissue. Indeed, triglyceride levels positively correlated with mitophagy-related genes and negatively with mitochondrial content markers. Moreover, mitochondria content and mitophagy markers seem to be significant predictors of hypertriglyceridemia and hypertriglyceridemia remission. CONCLUSIONS: Mitochondrial homeostasis of adipose tissue is altered in hypertriglyceridemic patients. At the protein level, mitochondria content and mitophagy are potential markers of hypertriglyceridemia remission in obese patients after bariatric surgery. These results may contribute to the implementation of a clinical approach for personalized medicine.
背景:肥胖和高三酰甘油血症的流行是一个令人震惊的全球健康问题。线粒体在这些疾病中起着核心作用,因为它们控制着细胞代谢。
目的:本研究旨在描述三级肥胖伴或不伴高三酰甘油血症患者皮下和内脏脂肪组织(SAT 和 VAT)中线粒体的稳态。此外,本研究评估了线粒体功能作为高三酰甘油血症改善的标志物。
患者:8 名对照和 12 名高三酰甘油血症(HTG)三级肥胖患者接受了减重手术。
主要观察指标:手术前后获得了人体测量学和生化数据。通过 SAT 和 VAT 中线粒体 DNA(mtDNA)、基因表达和蛋白质丰度评估线粒体稳态。
结果:HTG SAT 和 VAT 中的噬线粒体相关基因表达增加,而线粒体标记基因表达和 mtDNA 减少,表明 HTG 中线粒体稳态发生改变。在减重手术后未能降低其甘油三酯水平的患者中,VAT 中的噬线粒体蛋白丰度增加,而同一组织中的线粒体蛋白减少。事实上,甘油三酯水平与噬线粒体相关基因呈正相关,与线粒体含量标志物呈负相关。此外,线粒体含量和噬线粒体标志物似乎是肥胖患者高三酰甘油血症和高三酰甘油血症缓解的重要预测指标。
结论:脂肪组织的线粒体稳态在高三酰甘油血症患者中发生改变。在蛋白质水平上,线粒体含量和噬线粒体可能是肥胖患者减重手术后高三酰甘油血症缓解的潜在标志物。这些结果可能有助于实施个性化医学的临床方法。
J Clin Endocrinol Metab. 2022-7-14
J Acquir Immune Defic Syndr. 2013-10-1
Gastroenterology. 2015-5-28
Obesity (Silver Spring). 2013-5-19
J Gerontol A Biol Sci Med Sci. 2025-5-5
Mil Med Res. 2024-8-21
Rev Endocr Metab Disord. 2023-12
Nat Rev Cardiol. 2022-9
Front Endocrinol (Lausanne). 2020
Front Physiol. 2020-7-7
Cells. 2020-4-23
Eur Heart J. 2020-1-1
Int J Mol Sci. 2019-5-13